Trial intelligence / Profile preview

NIPS for Gastric Cancer With Peritoneal Metastasis

ChiCTR-IIR-16009802Phase 3Recruiting

Sponsor
Ruijin Hospital
Start
Jan 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of tegafur and paclitaxel in gastric adenocarcinoma (2 arms), sponsored by Ruijin Hospital. Primary endpoint: Overall survival. Started Jan 2017; status: recruiting.

02

Drugs

tegafurpaclitaxel
03

Conditions

gastric adenocarcinoma

Beyond the preview

Go deeper on ChiCTR-IIR-16009802.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IIR-16009802.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call